- Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Boehringer initiates trial of targeted therapy to treat Covid-19 patients

The TRPC6 inhibitor may alleviate the damage to the lung and decrease the risk or severity of acute respiratory complications in Covid-19 patients. Credit: MostafaElTurkey36 on Pixabay.